Visceral leishmaniasis is a worldwide health problem and is highly endemic in northeastern Brazil in the states of Rio Grande do Norte, Ceara and Bahia. It is typically caused by Leishmania chagasi, an intracellular protozoal pathogen of mammalian macrophages, which is transmitted by the sandfly, Lutzomyia longipalpis. Studies in rural endemic areas of Ceara indicate that approximately 5% of young children are infected each year. Of these, 1 in 8 develops progressive visceral leishmaniasis, which carries a mortality rate approaching 10%. The rest develop leishmania- specific CD4+ Th1 responses and have self-resolving infections. There is currently no effective form of immunoprophylaxis against L. chagasi and standard treatment of visceral leishmaniasis with glucantime, a pentavalent antimonial, is variably effective and frequently associated with toxicity. An accurate understanding of the immunobiology of human L. chagasi infection and identification of leishmanial antigens that elicit protective T cell responses are necessary if we are to develop an effective approach to immunoprophylaxis. Three central hypotheses that are critical to this end will be tested: (1) that L. chagasi-infected persons who exhibit Th1 responses as evidenced by secretion of interferon- gamma and interleukin-2 after self-resolving infection or successful treatment of progressive visceral leishmaniasis have long standing immunity that protects them against visceral leishmaniasis; (2) that L. chagasi antigens of 46 kDa, 41 kDa and 40 kDa are capable of eliciting potentially protective Th1 responses in individuals who have had self- resolving infection or who have undergone successful chemotherapy; and (3) that the susceptibility of humans to progressive visceral leishmaniasis is mediated by specific polymorphic alleles of the human Nramp gene and distinct HLA haplotype(s). The availability of a large number of L. chagasi-infected persons in both a well defined rural study area in the state of Ceara and in close proximity to research facilities in the city of Natal, Rio Grande do Norte, provides a unique opportunity to test these hypotheses. Completion of the proposed studies will provide data critical to the development of an effective approach to immunoprophylaxis for residents of northeastern Brazil and other endemic areas.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
5P50AI030639-08
Application #
6099489
Study Section
Project Start
1998-06-01
Project End
1999-05-31
Budget Start
Budget End
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Federal University of Bahia
Department
Type
DUNS #
900845397
City
Salvador
State
Country
Brazil
Zip Code
40110-160
Sousa, Rosana; Andrade, Viviane M; Bair, Thomas et al. (2018) Early Suppression of Macrophage Gene Expression by Leishmania braziliensis. Front Microbiol 9:2464
Silva, Silvana C; Guimarães, Luiz Henrique; Silva, Juliana A et al. (2018) Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients. Acta Trop 178:34-39
Kelly, Patrick H; Bahr, Sarah M; Serafim, Tiago D et al. (2017) The Gut Microbiome of the Vector Lutzomyia longipalpis Is Essential for Survival of Leishmania infantum. MBio 8:
Gimblet, Ciara; Meisel, Jacquelyn S; Loesche, Michael A et al. (2017) Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation. Cell Host Microbe 22:13-24.e4
Almeida, Lucas; Silva, Juliana A; Andrade, Viviane M et al. (2017) Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection. Infect Genet Evol 49:212-220
Weirather, Jason L; Duggal, Priya; Nascimento, Eliana L et al. (2017) Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil. Ann Hum Genet 81:41-48
Novais, Fernanda O; Carvalho, Augusto M; Clark, Megan L et al. (2017) CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1? production. PLoS Pathog 13:e1006196
Cincurá, Carolina; de Lima, Clara Mônica F; Machado, Paulo R L et al. (2017) Mucosal leishmaniasis: A Retrospective Study of 327 Cases from an Endemic Area of Leishmania (Viannia) braziliensis. Am J Trop Med Hyg 97:761-766
Carvalho, Augusto M; Fukutani, Kiyoshi F; Sharma, Rohit et al. (2017) Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasis. Sci Rep 7:3149
Davis, Richard E; Sharma, Smriti; Conceição, Jacilara et al. (2017) Phenotypic and functional characteristics of HLA-DR+ neutrophils in Brazilians with cutaneous leishmaniasis. J Leukoc Biol 101:739-749

Showing the most recent 10 out of 85 publications